基于质控与临床样本重校准实现两种hs-cTnI方法 harmonization
研究评估用线性回归模型对EQA和临床样本重校准能否协调两种hs-cTnI方法。先用16份EQA样本建立模型,再用12家医院2530份肝素血浆验证。重校准后两法偏差显著降低,hs-cTnI≤500 ng/L时均值CV从38.4%降至15.0%(n=13,P=0.0111)。
要点
- 基于EQA和临床样本均值线性回归重校准可显著降低两种hs-cTnI方法间系统偏差。
- 重校准后方法间一致性提高约2.5倍,hs-cTnI≤500 ng/L时CV从38.4%降至15.0%。
- 该协调方法适用于单克隆抗体结合特性相似的hs-cTnI方法。
核心结论
- 基于两种hs-cTnI方法测量浓度均值的重校准程序可显著降低系统偏差,改善方法间协调性。
研究设计与样本
- 两步实验:先用16份EQA样本建立线性回归重校准模型,再用12家意大利大学和区域医院收集的2530份肝素血浆样本验证。
主要发现
- 重校准后两法间测量偏差显著降低,方法间一致性提高约2.5倍。
- hs-cTnI≤500 ng/L时(n=13),均值CV从重校准前38.4%(SD 25.9%)降至重校准后15.0%(SD 10.6%),P=0.0111(非参数配对检验)。
关键数值与推荐
- 重校准模型基于两种hs-cTnI方法测量值的均值线性回归。
- 协调效果以均值CV评估:重校准前38.4%(SD 25.9%),重校准后15.0%(SD 10.6%),hs-cTnI≤500 ng/L,n=13,P=0.0111。
临床怎么用
- 检验科和临床医生可借助该重校准方法更好地比较Architect和Access hs-cTnI方法的测量浓度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The study aim was to evaluate whether is possible to harmonize the results of two hs-cTnI methods using a recalibration procedure based on linear regression models and measured values of external quality assessment (EQA) and clinical samples. METHODS: A two-step experimental approach was used. The preliminary step was performed using 16 EQA samples. The harmonization procedure was then validated by using 2530 heparinized plasma samples collected by 12 Italian University and Regional Hospitals from apparently healthy volunteers and patients admitted to emergency department with cardiac diseases. Two hs-cTnI methods were tested: Architect Stat High Sensitive Troponin-I, and the Access hs-cTnI using DxI platform. Linear regression models based on mean values measured with the two hs-cTni methods were used. RESULTS: A significant reduction in the measurement bias between the two methods was found after recalibration procedure. The agreement between-methods improved of about 2.5 folds after recalibration, as assessed by reduction in mean CV values from 38.4% (SD 25.9%) before recalibration to 15.0% (SD 10.6%) after recalibration for hs-cTnI values ≤ 500 ng/L (n = 13, P = 0.0111 by non-parametric test for paired data). CONCLUSIONS: A recalibration procedure based on means of measured concentrations with hs-cTnI methods, which use monoclonal antibodies with similar binding characteristics, can be used to significantly reduce systematic bias and so to improve harmonization between methods. The results of this study can aid laboratorians and clinicians to better compare the concentrations respectively measured with the Architect and Access hs-cTnI methods.
引用
- Clerico A, Zaninotto M, Padoan A, et al. Harmonization of two hs-cTnI methods based on recalibration of measured quality control and clinical samples. Clin Chim Acta. 2020. PMID: 32652160. doi:10.1016/j.cca.2020.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。